Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 11:40 PM ET

Biotechnology

Company Overview of Lipella Pharmaceuticals, Inc.

Company Overview

Lipella Pharmaceuticals, Inc., a development-stage biotechnology company, focuses on the development and commercialization of topical liposomal formulations for interstitial cystitis, hemorrhagic cystitis, and overactive bladder therapeutic applications. The company is engaged in developing novel products, which focus on trans-mucosal therapy by delivering local treatments directly to their site of action. It focuses on various therapeutic areas, such as urology, including interstitial cystitis, overactive bladder, hemorrhagic cystitis, and bladder cancer; gastroenterology, including eosinophilic esophagitis; ear, nose, and throat, including chronic rhinitis; and dermatology. The company was...

400 North Lexington Avenue LL103

Pittsburgh, PA 15208

United States

Founded in 2005

Phone:

412-894-1853

Fax:

267-295-2073

Key Executives for Lipella Pharmaceuticals, Inc.

Co-Founder, Chairman of The Board, Chief Executive Officer and President
Chief Financial Officer
Director of Operations
Chief Medical Officer, Executive Vice President and Director
Director of Marketing
Compensation as of Fiscal Year 2015.

Lipella Pharmaceuticals, Inc. Key Developments

Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM

Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Michael B. Chancellor, Chief Medical Officer, Executive Vice President and Director.

Similar Private Companies By Industry

Company Name Region
Accellient Partners, LLC United States
Neurotech Pharmaceuticals, Inc. United States
Reviva Pharmaceuticals Inc. United States
Hedral Therapeutics, Inc. United States
InCytu, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lipella Pharmaceuticals, Inc., please visit www.lipella.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.